Compare CDNA & ARCB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CDNA | ARCB |
|---|---|---|
| Founded | 1998 | 1923 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical Specialities | Trucking Freight/Courier Services |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.6B | 3.1B |
| IPO Year | 2007 | 1994 |
| Metric | CDNA | ARCB |
|---|---|---|
| Price | $66.83 | $129.52 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 7 | 14 |
| Target Price | $58.83 | ★ $170.92 |
| AVG Volume (30 Days) | ★ 1.0M | 176.4K |
| Earning Date | 11-03-2026 | 11-04-2026 |
| Dividend Yield | N/A | ★ 0.38% |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 2.13 | N/A |
| Revenue | $48,324,000.00 | ★ $1,657,864,000.00 |
| Revenue This Year | $30.36 | $12.05 |
| Revenue Next Year | $6.23 | $7.67 |
| P/E Ratio | $30.04 | ★ N/A |
| Revenue Growth | ★ 18.93 | 12.56 |
| 52 Week Low | $13.95 | $59.43 |
| 52 Week High | $65.50 | $176.69 |
| Indicator | CDNA | ARCB |
|---|---|---|
| Relative Strength Index (RSI) | 78.88 | 39.11 |
| Support Level | $17.26 | $115.28 |
| Resistance Level | N/A | $142.33 |
| Average True Range (ATR) | 2.87 | 4.01 |
| MACD | 0.90 | -0.13 |
| Stochastic Oscillator | 99.39 | 20.19 |
CareDx Inc operates as a precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers. It offers testing services, products, and digital solutions along with the pre- and post-transplant patient journey and is a provider of genomics-based information for transplant patients. The Company's commercially available testing services consist of AlloSure Kidney, AlloMap Heart, AlloSure Heart, a dd-cfDNA solution for heart transplant patients, and AlloSure Lung, a dd-cfDNA solution for lung transplant patients. Geographically it generates the majority of its revenue from the United States. The company generates the majority of revenue from the Testing services.
ArcBest Corp is an integrated logistics company that leverages technology and a full suite of shipping and logistics solutions to meet customers' supply chain needs. The company has two reportable operating segments: Asset-Based, which generates maximum revenue, and Asset-Light. The Asset-Based segment's operations include national, inter-regional, and regional transportation of general commodities through standard, expedited, and guaranteed less-than-truckload services. The Asset-Light segment represents the company's offerings in ground expedite, intermodal, household goods moving, managed transportation, warehousing and distribution, and international freight transportation for air, ocean, and ground.